Editor's Column — Scribbles
Yet another issue of Scribe has been published today. I am proud to inform you that ISPE members from three continents have written exclusive articles for Scribe in this issue....click here for more

Notice of Meeting: Antidepressants and Suicides
The U.S. Food and Drug Administration's Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee will discuss reports of the occurrence of suicidality (both suicidal ideation and suicide attempts) in clinical trials for various antidepressant drugs in pediatric patients with major depressive disorder and other psychiatric disorders...click here for more

Bienvenue à Bordeaux
By Mark H. Epstein
In this year of Olympian events, I am delighted to tell you the names of Nicholas Moore, Annie Fourrier-Reglat, Cees Schep, Nancy Dreyer, Kuni Hayashi, Nicole Hartnell, and countless other ISPE volunteers will be etched into the record book for their dazzling performances in Bordeaux....click here for more

Drug Induced Liver Injury Network (DILIN) Formed
By Susan Pusek, MD, Study Coordinator, DILIN, University of North Carolina
Drug-induced liver injury (DILI) is the most common cause for acute liver failure in the U.S. DILI is also the most common safety issue leading to regulatory actions including withdrawal of drugs from the market, restrictions in indications, and warnings to physicians and patients...click here for more

CERTs: An ISPE Partner in Improving the Knowledge and Use of Pharmaceuticals through Research and Education
By Hugh Tilson, MD, DrPH, FISPE, and Leanne Madre, JD
Let us introduce an important strategic partner to ISPE, the U.S.-based national program of the Centers for Education and Research on Therapeutics (CERTs)...click here for more

FDA's Dr. Seligman works with CERTs to Optimize Use of Therapeutics
By Patrick E. Clarke, FDA, CDER
ISPE member Paul Seligman, M.D., M.P.H., is one of two U.S. FDA members on the steering committee for the Centers for Education and Research on Therapeutics (CERTs)...click here for more

WHO Aims for Safety in the Use of Traditional Medicines
By Jill Moss
The World Health Organization says people need more information about how to safely use traditional medicines...click here for more

Brian L. Strom
ScribeLine
Which medical school did you graduate from and when?
Johns Hopkins, 1975. Did a fellowship in Clinical Pharmacology at University of California, San Francisco, under the late Ken Melmon who died recently.. click here for more

The Full Feature General Practice Research Database (FF-GPRD): an Update
By Louise Wood, MD, Director, GPRD
It's just over five years since the U.K. Medicines Control Agency (now MHRA - Medicines and Healthcare products Regulatory Agency) assumed management responsibility for the U.K.'s General Practice Research Database (GPRD)...click here for more

U.K. Government Announces Winners of £4 million Research into Pharmacogenetics
Genetics could help doctors to predict the best treatment for patients
U.K. Health Minister Lord Warner recently announced the winning bids for £4 million of funding into pharmacogenetics — how a patient's genetic make-up can effect their response to different medicines...click here for more

Pharmacovigilance and Pharmacoepidemiology at CPT2004
By Richard Hill and John McEwen, Therapeutic Goods Administration (TGA), Department of Health and Ageing, Australia)
The Eighth World Congress on Clinical Pharmacology and Therapeutics (CPT; www.cpt2004.com) was held in Brisbane, the State capital of Queensland, Australia, from August 1-6, 2004...click here for more

Phenylpropanolamine (PPA) Banned in Korea and FDA Chief Resigns
The Ministry of Health and Welfare recently concluded that the Korean Food and Drug Administration (KFDA) have taken belated measures to ban PPA-containing cold and cough medicines...click here for more